佩病治疗的进步:从酶替代到基因疗法
1Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94305, USA. pcolella@stanford.edu.
Molecular diagnosis & therapy
|August 12, 2024
概括
庞培病是一种神经肌肉疾病,正在使用基因疗法等新疗法来治疗. 有希望的结果表明,这些先进的治疗方法可能为这种罕见的遗传疾病提供潜在的治疗方法.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 神经学 神经学
背景情况:
- 庞培病是一种罕见的神经肌肉疾病,由酸α-葡萄糖酶 (GAA) 缺乏引起,导致肌肉细胞中糖原的积累.
- 它呈现为婴儿发病 (IOPD) 和晚发病 (LOPD) 形式,导致严重的心脏,运动和呼吸系统问题.
- 目前的酶替代疗法 (ERT) 提供了好处,但不是治愈.
研究的目的:
- 审查佩病治疗的最新进展,重点关注酶替代疗法 (ERT) 和新兴的治疗策略.
- 讨论基因疗法的进展和潜力,作为婴儿和晚期爆发的庞培病的新疗法.
- 突出了庞培病的一次性治愈治疗的潜力.
主要方法:
- 对佩病的酶替代疗法 (ERT) 最近进展的审查.
- 对正在进行的翻译研究进行分析,包括使用腺相关病毒 (AAV) 载体进行基因治疗临床试验 (I/II期).
- 对基因和基底减少疗法的临床前发展进行评估.
主要成果:
- 第二代ERT已经获得批准,胎内ERT正在临床试验中.
- 使用AAV载体的基因治疗试验显示出有希望的结果,许多LOPD参与者在治疗后停止了ERT.
- 临床前研究正在推进基因和基底减少疗法.
结论:
- 在开发佩病治愈疗法方面取得了重大进展.
- 基因疗法,特别是AAV载体,显示出一次性治疗的潜力,早期数据非常令人鼓舞.
- 尽管仍然存在挑战,但新兴疗法为庞培病的功能治疗提供了希望.
相关概念视频
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
What is Genetic Engineering?
73.9K
Overview
73.9K


